天发娱乐棋牌_天发娱乐APP-官网|下载 trial opens to recruitment in 天发娱乐棋牌_天发娱乐APP-官网|下载
People across the south are to be part of pioneering research into new 天发娱乐棋牌_天发娱乐APP-官网|下载 treatments.
A ground-breaking clinical trial platform being led by researchers at the 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Trials Unit is now recruiting patients through the NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Research Facility within the General Hospital.
The aim of the national AGILE platform is to fast-track potential new 天发娱乐棋牌_天发娱乐APP-官网|下载 treatments through early phase clinical trials to help find drugs which can prevent people who contract the virus from becoming severely ill.
Professor Gareth Griffiths, Director of the NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Trials Unit, said:
“The UK’s 天发娱乐棋牌_天发娱乐APP-官网|下载 vaccination programme has been a huge success and has led to a decrease in infection and hospitalisation rates. However, it will not irradicate 天发娱乐棋牌_天发娱乐APP-官网|下载 infections entirely and it is therefore essential that we continue to find treatments for those people who do contract the virus to prevent them from developing the most severe symptoms and protect them from future infections.”
“In order to carry out this vital research, we rely on volunteer trial participants to help us see which treatments will be most effective. We are therefore asking people across the south to consider taking part in the AGILE trial if they meet the trial requirements.”
AGILE was launched in July 2020, and the first treatment in the drug testing platform entered into patient trials in Liverpool in September.
Now trials are also opening at the NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Research Facility, based within University Hospital 天发娱乐棋牌_天发娱乐APP-官网|下载 NHS Foundation Trust, and people from across the South are being encouraged to take part in the trials and help move 天发娱乐棋牌_天发娱乐APP-官网|下载 research forward.
Professor Christopher Edwards, Associate Director of the 天发娱乐棋牌_天发娱乐APP-官网|下载 CRF and Principal Investigator for AGILE in 天发娱乐棋牌_天发娱乐APP-官网|下载, said:
“We are delighted that the AGILE platform is now recruiting patients in 天发娱乐棋牌_天发娱乐APP-官网|下载. The NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 CRF has already been involved in other 天发娱乐棋牌_天发娱乐APP-官网|下载 trials and we have experience with early phase studies.”
“We hope that people across the south coast will be motivated to be involved in this ground-breaking research and help us to help find new treatments to combat this virus which has affected so many.”
The UK Government recently announced its support for the AGILE platform with ?3.2m of funding awarded by the Medical Research Council and co-funded through the National Institute of Health Research (NIHR) to allow AGILE’s activity to be expanded into more UK centres.
To find out more, please contact the AGILE team at the 天发娱乐棋牌_天发娱乐APP-官网|下载 CRF on 07469 565 895 or email UHS.天发娱乐棋牌_天发娱乐APP-官网|下载CRF@nhs.net .
Notes for editors
AGILE is an academic clinical trial platform led by the University of Liverpool and the NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Trial Unit, in partnership with researchers from the Liverpool Tropical School of Medicine, NIHR Liverpool and Broadgreen Clinical Research Facility and Lancaster University. It has been established to enable the rapid clinical evaluation of potential COVID19 therapeutics across the UK CRF Network. Visit the AGILE website .
The 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Trials Unit (CTU) is a National Institute for Health Research (NIHR) supported CTU with expertise in the design, conduct and analysis of multicentre, interventional clinical trials. The CTU is based within the University of 天发娱乐棋牌_天发娱乐APP-官网|下载 with offices at the University Hospital 天发娱乐棋牌_天发娱乐APP-官网|下载 NHS Foundation Trust 天发娱乐棋牌_天发娱乐APP-官网|下载 General Hospital site. Visit the SCTU website .
The NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Clinical Research Facility (CRF) is one of 19 NIHR clinical research facilities networked across the UK, giving superb access to research expertise and infrastructure. The CRF is where the latest scientific developments first enter the clinic, both from our own laboratories and from leading companies. Visit the CRF website .
University Hospital 天发娱乐棋牌_天发娱乐APP-官网|下载 NHS Foundation Trust provides services to some?1.9 million?people living in 天发娱乐棋牌_天发娱乐APP-官网|下载 and south Hampshire, plus specialist services such as neurosciences, cardiac services and children's intensive care to more than 3.7 million people in central southern England and the Channel Islands. The?Trust is also a major centre for teaching and research in association with the University of 天发娱乐棋牌_天发娱乐APP-官网|下载 and partners including the Medical Research Council and Wellcome Trust. Visit the UHSFT website .
The?University of 天发娱乐棋牌_天发娱乐APP-官网|下载 is?among the top?90?institutions globally (QS World University Rankings 2021) and top?15?in the UK (The Times?and?The Sunday Times?Good University Guide?2021). As a founding member of the Russell Group, we are committed to?using our knowledge to help shape economic, cultural and intellectual decisions, playing a part in researching solutions to national and global issues. Visit the University’s website .
For more information on the Government’s support for AGILE platform and the ?3.2m funding boost from the MRC and NIHR, please see the Department for Health and Social Care’s press release .